Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
06 Septiembre 2023 - 3:30PM
Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for
active healing, today announced that Tony Bihl, interim chief
executive officer, will participate in a fireside chat at the
Morgan Stanley Global Healthcare Conference on Wednesday, September
13, 2023, at 8:50 a.m. ET.
A live audio webcast of the fireside chat will be available on
the “Investors” section of the Company’s website at
www.bioventus.com and will be available for replay on that site
following the event.
About BioventusBioventus delivers clinically
proven, cost-effective products that help people heal quickly and
safely. Its mission is to make a difference by helping patients
resume and enjoy active lives. The Innovations for Active Healing
from Bioventus include offerings for Pain Treatments, Restorative
Therapies and Surgical Solutions. Built on a commitment to high
quality standards, evidence-based medicine and strong ethical
behavior, Bioventus is a trusted partner for physicians worldwide.
For more information, visit www.bioventus.com, and follow the
Company on LinkedIn and Twitter. Bioventus and the Bioventus logo
are registered trademarks of Bioventus LLC.
Investor and Media Contact:Dave
Crawford919-474-6787dave.crawford@bioventus.com
Bioventus (NASDAQ:BVS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Bioventus (NASDAQ:BVS)
Gráfica de Acción Histórica
De May 2023 a May 2024